Cargando…
Use of Disease-Modifying Therapies in Pediatric Relapsing-Remitting Multiple Sclerosis in the United Kingdom
OBJECTIVES: To compare the real-world effectiveness of newer disease-modifying therapies (DMTs) vs injectables in children with relapsing-remitting multiple sclerosis (RRMS). METHODS: In this retrospective, multicenter study, from the UK Childhood Inflammatory Demyelination Network, we identified ch...
Autores principales: | Abdel-mannan, Omar A., Manchoon, Celeste, Rossor, Thomas, Southin, Justine-Clair, Tur, Carmen, Brownlee, Wallace, Byrne, Susan, Chitre, Manali, Coles, Alasdair, Forsyth, Rob, Kneen, Rachel, Mankad, Kshitij, Ram, Dipak, West, Siobhan, Wright, Sukhvir, Wassmer, Evangeline, Lim, Ming, Ciccarelli, Olga, Hemingway, Cheryl, Hacohen, Yael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143699/ https://www.ncbi.nlm.nih.gov/pubmed/34021056 http://dx.doi.org/10.1212/NXI.0000000000001008 |
Ejemplares similares
-
Clinical features, investigations, and outcomes of pediatric limbic encephalitis: A multicenter study
por: Sabanathan, Saraswathy, et al.
Publicado: (2022) -
Baló’s concentric sclerosis presenting asymptomatically in a child: clinico-radiological-pathological correlation
por: Southin, Justine-Clair, et al.
Publicado: (2023) -
Alemtuzumab: evidence for its potential in relapsing—remitting multiple sclerosis
por: Brown, JWL, et al.
Publicado: (2013) -
N-methyl-D-aspartate receptor antibody-mediated neurological disease: results of a UK-based surveillance study in children
por: Wright, Sukhvir, et al.
Publicado: (2015) -
Development and Validation of a Targeted Next-Generation Sequencing Gene Panel for Children With Neuroinflammation
por: McCreary, Dara, et al.
Publicado: (2019)